In recent years, the increasing availability of individual-level data and the advancement of machine learning algorithms have led to the explosion of methodological development for finding optimal individualized treatment rules (ITRs). These new tools are being applied in a variety of fields including business, medicine, and politics. However, there exist few methods that empirically evaluate the efficacy of ITRs. In particular, many of the existing ITR estimators are based on complex models and do not come with statistical uncertainty estimates. We consider common real-world settings, in which policy makers wish to predict the performance of a given ITR prior to its administration in a target population. We propose to use a randomized experiment for evaluating ITRs. Unlike the existing methods, the proposed methodology is based on Neyman's repeated sampling approach and does not require modeling assumptions. As a result, it is applicable to the empirical evaluation of ITRs derived from a wide range of statistical and machine learning models. We conduct a simulation study to demonstrate the accuracy of the proposed methodology in small samples. We also apply our methods to the Project STAR (Student-Teacher Achievement Ratio) experiment to compare the performance of ITRs that are based on popular machine learning methods used for estimating heterogeneous treatment effects.
Introduction
In recent years, the increasing availability of individual-level data and the rapid development of machine learning methods have led to the application of individualized treatment rules (ITRs) in a variety of fields, which assign different treatments to individuals based on their observed characteristics. Examples include personalized medicine and micro-targeting in business and political campaigns (e.g., Hamburg and Collins, 2010; Imai and Strauss, 2011) . In the causal inference literature, a number of researchers have developed methods to estimate ITRs, while others have applied machine learning methods for estimating heterogeneous treatment effects, which can then be used to construct ITRs.
Despite these advancements in methodological development and empirical applications, however, there exist few methods that empirically evaluate the performance of ITRs. In particular, many existing ITR estimators based on machine learning methods do not come with statistical uncertainty measures (e.g., Qian and Murphy, 2011; Zhao et al., 2012; Imai and Ratkovic, 2013; Laber and Zhao, 2015; Fu, Zhou and Faries, 2016; Zhou et al., 2017; Künzel et al., 2018) , while others only provide asymptotic, model-based standard errors (e.g., Brinkley, Tsiatis and Anstrom, 2010; Cai et al., 2010; Zhang et al., 2012) . In addition, some of the new methods for estimating heterogeneous treatment effects rely on variants of bootstrap and Bayesian posterior sampling methods to obtain uncertainty estimates about the conditional average treatment effects given individual characteristics (e.g., Athey and Imbens, 2016; Hahn, Murray and Carvalho, 2017; Wager and Athey, 2018) . Nevertheless, it is not immediately clear how conditional variances about average treatment effects can be used to conduct inference for the population performance of the ITRs. Finally, the results of the 2017 Atlantic Causal Inference Conference Data Analysis
Challenge suggest that these model-based and resampling-based confidence intervals may have poor coverage in practice when estimating heterogeneous treatment effects (see Hahn, Dorie and Murray, 2018 , for details).
To address this problem, we propose to use the data from a randomized experiment for evaluating the efficacy of ITRs. In particular, we consider common real-world settings, in which policy makers wish to predict the performance of a given ITR prior to its administration in a target population. Since an ITR of interest is given, we do not consider its estimation uncertainty concerning.
Rather, the uncertainty comes from the fact that we do not know how the ITR would perform if administered to the target population. Our methodology, which is based on the classical repeated sampling approach of Neyman (1923) , has several advantages over the existing methods. Specifically, the proposed methodology does not depend on any modeling assumptions or asymptotic approximations used to construct ITRs. It does not require computationally intensive methods such as bootstrap, which could only capture the uncertainty across samples and not treatment.
In fact, the uncertainty estimates are based solely on the randomization of treatment assignment and the random sampling of experimental units. As a result, it is applicable to the empirical evaluation of ITRs derived from a wide range of statistical and machine learning methods.
We begin by introducing the Population Average Prescriptive Effect (PAPE) as one measure of ITR's efficacy (Section 2.2). The PAPE is defined as the difference between the average outcomes under an ITR and the random treatment rule, which randomly selects the same number of individuals to be treated as the number of indviduals treated under the ITR. Much of the existing methodology literature uses the value or the average outcome under an ITR, as an evaluation metric (e.g., Qian and Murphy, 2011; Zhao et al., 2012) . In contrast, we argue that when evaluating the efficacy of an ITR, it is important to hold the number of treated units constant. Otherwise, if a treatment has a non-negative effect on all individuals, for example, we would conclude that treating everyone will be an optimal strategy. While the PAPE has been used by others (e.g., Imai and Strauss, 2011; Rzepakowski and Jaroszewicz, 2012; Gutierrez and Gérardy, 2016; Fifield, 2018) , a formal statistical analysis has not been conducted. We propose an unbiased estimator of the PAPE and derive its variance.
We also consider the PAPE under a budget constraint (Section 2.3). As most policy makers have a limited amount of resources, establishing the priority as to who should receive the treatment is essential. Under this setting, we propose an approximately unbiased estimator of the PAPE and its variance. Since the efficacy of an ITR can vary as a function of budget constraint, we define the Area under the Prescriptive Effect Curve (AUPEC), which summarizes the relative advantage of the ITR over the random treatment rule. The AUPEC averages the PAPE over a specified range of budget constraint (Section 2.4). Again, we propose an approximately unbiased estimator of the AUPEC and derive its variance.
As the third evaluation metric, we consider the Population Average Prescriptive Effect Differ-ence (PAPD), which quantifies the difference in the average outcome under two ITRs with the same budget constraint (Section 2.5). Unlike the usual comparison based on the value of ITRs, the PAPD holds the maximal proportion of treated units constant and hence puts two ITRs on an equal footing. The PAPD also generalizes the PAPE as the latter is a comparison against the random treatment rule. We propose an approximately unbiased estimator of the PAPD. Although the repeated sampling variance of this estimator is unidentifiable, we derive its upper bound, which yields a conservative estimate of the variance.
Next, we analytically compare the statistical efficiency of this ex-post experimental evaluation over the ex-ante experimental evaluation, in which individuals are randomly assigned to either an ITR or a random treatment rule (Section 2.6). Unfortunately, a definitive conclusion on the statistical efficiency of two approaches is difficult to draw because the comparison depends on many parameters. Nevertheless, we show that under a set of simplifying assumptions, the ex-post experimental evaluation presented in this paper is statistically more efficient than the ex-ante evaluation. One reason is that the ex-post evaluation utilizes the entire experimental sample to estimate the average outcomes under both the ITR of interest and the random treatment rule while the ex-ante evaluation uses a separate part of the sample for each treatment rule.
In Section 3, we conduct a simulation study to evaluate the ITRs based on three machine learning methods -Bayesian Additive Regression Tree Carvalho, 2017), Causal Forest (Wager and Athey, 2018) , and LASSO (Tibshirani, 1996) . The set up of our simulation study follows that of the aforementioned 2017 Atlantical Causal Inference Conference Data Challenge, in which the focus of the competition was the estimation of conditional average treatment effect. We show that even in the sample size as small as 100 the confidence intervals based on the proposed variance estimators have empirical coverage rates close to the nominal rates for the proposed quantities of interest.
In Section 4, we apply the proposed methodology to the Tennessee's Student/Teacher Achievement Ratio (STAR) Project, which experimentally examines the efficacy of small class on students' performance. Using this experimental data, we show how to evaluate the ITRs based on the aforementioned three machine learning methods. We find that these ITRs do not significantly improve upon the random treatment rule when there is no budget constraint in part because small classes have a non-negative effect on many students. However, when we impose a budget constraint, the ITRs based on BART and Causal Forest significantly outperforms the random treatment rule by identifying a subset of students who benefit greatly from small class. Our analysis shows that in this application the ITR based on Causal Forest performs best, followed by BART and then LASSO.
Finally, Section 5 gives concluding remarks. We briefly discuss how the proposed evaluation framework can be extended to other settings including dynamic optimal treatment regimes and network experiments.
The Proposed Methodology
In this section, we describe the proposed methodology. We introduce four evaluation metrics for ITRs, propose their estimators, and derive the bias and variance under the repeated sampling framework of Neyman (1923) . We also compare the statistical efficiency of ex-post experimental evaluation with that of ex-ante experimental evaluation.
The Setup and Assumptions
Suppose that policy makers wish to predict the performance of a given individualized treatment rule (ITR) f prior to its administration in a target population, P. Formally, we define the ITR as a fixed and deterministic map from the covariate space to the binary treatment assignment (Qian and Murphy, 2011; Zhao et al., 2012) ,
where X is the support of covariates X. We consider an experimental evaluation of the ITR. Since the ITR is given, we do not consider its estimation uncertainty. Rather, the uncertainty comes from the fact that we do not know how the ITR would perform if administered to the target population.
Assume that we have a simple random sample of n units from the population of interest, P.
We conduct a completely randomized experiment in which n 1 > 2 units are randomly assigned to the treatment condition with probability n 1 /n and the rest of n 0 (= n − n 1 ) units are assigned to the control condition. Let T i denote the treatment assignment indicator variable, which is equal to 1 if unit i is assigned to the treatment condition. For each unit, we observe the outcome variable Y i ∈ Y as well as a vector of pre-treatment covariates, X i ∈ X , where Y and X are the support of the outcome and covariates, respectively. We assume no interference between units and denote the potential outcome for unit i under the treatment condition T i = t as Y i (t) for t = 0, 1. Then, the observed outcome is given by
We formally state these assumptions as follows.
Assumption 1 (No Interference between Units) The potential outcomes for unit i do not depend on the treatment status of other units. That is, for all t 1 , t 2 , . . . , t n ∈ {0, 1}, we have,
Assumption 2 (Random Sampling of Units) Each of n units, represented by a three-tuple consisting of two potential outcomes and pre-treatment covariates, is assumed to be independently sampled from a super-population P, i.e.,
∼ P
Assumption 3 (Complete Randomization) For any i = 1, 2, . . . , n, the treatment assignment probability is given by,
While it is straightforward to allow for unequal treatment assignment probabilities across units, for the sake of simplicity, we assume complete randomization.
Evaluation against the Random Treatment Rule
Our goal is to evaluate the efficacy of an individualized treatment rule (ITR). In the literature, researchers often evaluate the population average value (PAV) of an ITR (e.g., Qian and Murphy, 2011; Zhao et al., 2012; Zhang et al., 2012; Zhou et al., 2017) , which is defined as the (superpopulation) average potential outcome under the ITR,
We argue that when evaluating an ITR, it is important to consider the proportion of units which are assigned to the treatment condition. Since a treatment is often costly in practice, the efficacy of an ITR must be examined while holding the number of treated units constant. We do so by comparing an ITR against the random treatment rule, which randomly selects the same number of treated units (see e.g., Imai and Strauss, 2011; Rzepakowski and Jaroszewicz, 2012; Gutierrez and Gérardy, 2016; Fifield, 2018) .
Formally, let p f = Pr(f (X i ) = 1) denote the proportion of units assigned to the treatment condition under the individualized treatment assignment rule f , where we assume 0 < p f < 1.
Then, we can define the population average prescription effect (PAPE) of an ITR over the random treatment rule as,
where the PAV of the random treatment rule is given by
the statistical inference about the PAPE from Neyman's repeated sampling approach (Neyman, 1923) . We propose the following estimator of the PAPE,
The next theorem shows the unbiasedness of this estimator and derives its variance.
Theorem 1 (Unbiasedness and Variance of the Proposed Estimator for the PAPE) Under Assumptions 2-3, the bias and variance of the estimator of the PAPE given in equation (2) are given by,
Proof is given in Appendix A.1. Note that E(S 2 f t ) = V(Y * i (t)) because the proportion of treated units p f is unknown and estimated. The additional term in the variance accounts for the estimation uncertainty of p f . In addition, the variance of the proposed estimator can be consistently estimated by replacing the unknown terms, i.e., p f , τ f , τ , E(S 2 f t ), with their unbiased estimates, i.e.,p f ,τ f ,
where
Evaluation with a Budget Constraint
In many practical situations, the evaluation of ITRs requires the consideration of a budget contraint. The evaluation strategy discussed above assumes that there is no limit on the number of individuals assigned to the treatment condition. Here, we operationalize a budget constraint as the maximal proportion of treated units, denoted by p, and consider the setting, in which this proportion is less than the proportion of units to be treated under an ITR, i.e., p < p f . Note that if p ≥ p f , then a budget constraint is not binding and hence the results of Section 2.2 directly apply.
With a budget constraint, we cannot simply treat all units who are predicted to benefit from the treatment. Instead, an ITR must be based on a score function that orders units according to their treatment priority. That is, a unit with a greater score has a higher priority to receive the treatment. Let s : X −→ S be such a score function where S ⊂ R. For the sake of simplicity, we assume that the score function is bijective, i.e., s(x) = s(x ) for any x, x ∈ X with x = x .
This assumption is not restrictive as we can always redefine X such that the assumption holds. A prominent example of score function is the conditional average treatment effect (CATE),
A number of researchers have studied how the CATE can be best estimated using various machine learning methods such as regularized regression models and tree-based methods (e.g., Imai and Strauss, 2011; Qian and Murphy, 2011; Imai and Ratkovic, 2013; Athey and Imbens, 2016; Grimmer, Messing and Westwood, 2017; Künzel et al., 2018; Wager and Athey, 2018) .
We now define an ITR based on a score function by assigning a unit to the treatment group if and only if its score is higher than a threshold, c p
Since we are considering the case with a binding budget constraint, the threshold c p corresponds to the maximal proportion of treated units under the budget constraint, i.e.,
Following the idea discussed above, we evaluate an ITR f against the random treatment rule, which randomly selects p proportion of units for the treatment group. Thus, we define the PAPE with a budget constraint p as,
We consider the following estimator of the PAPE with a budget constraint,
As before, we examine the bias and variance under Neyman's repeated sampling framework. ince we are also estimating c p , the bias of the proposed estimator in equation (4) is not zero. However, we can derive its upper bound.
Theorem 2 (Bias and Variance of the Proposed Estimator for the PAPE with a Budget Constraint) Under Assumptions 2-3, the bias of the proposed estimator of the PAPE with a budget constraint p defined in equation (4) can be bounded as follows,
where any given constant > 0, B( , α, β) is the incomplete beta function, and
The variance of the estimator is given by,
where, for t = 0, 1,
] due to the need to estimate c p . The additional term in the variance accounts for the variance due to estimating c p . As before, the variance can be consistently estimated by replacing each unknown parameter with its sample analogue, i.e., for t = 0, 1,
To estimate the term that appears in the denominator of γ p ( ) as part of the upper bound of bias, we may assume that the CATE
The Lipschitz continuity of the CATE is often assumed when estimating heterogeneous treatment effects (see e.g., Künzel et al., 2018; Wager and Athey, 2018) .
Area Under Prescriptive Effect Curve (AUPEC)
The PAPE defined in equation (3) varies as a function of budget constraint. Figure 1 shows this graphically where the horizontal and vertical axes represent the budget and the average outcome, respectively. In the figure, the red solid curve corresponds to the average outcome under an ITR, i.e., E{Y i (f (X i , c p )}, as a function of budget constraint p, whereas the black solid line represents the average outcome under the random treatment rule. We may wish to evaluate the overall efficacy of an ITR by computing the area under the red curve minus the area under the black curve. This is shown as a shaded area in Figure 1 , and we call it the Area Under the Prescriptive Effect Curve (AUPEC). Formally, we define the AUPEC as,
Thus, the AUPEC represents the average performance relative to the random treatment rule over the entire range of budget constraint. Although a similar idea is proposed in the literature (see e.g., Rzepakowski and Jaroszewicz, 2012) , unlike the previous work, we do not require an individualized treatment rule to assign the maximal number of units to the treatment condition under a budget constraint. For example, treating more than a certain proportion of units may reduce the average outcome because these additional units do not benefit from the treatment.
Budget, p
Average outcome 
Then, we propose the following estimator of the AUPEC,
whereĉ p = inf{c ∈ R :
The following theorem bounds the bias and derives the variance of this estimator under Neyman's repeated sampling approach.
Theorem 3 (Bias and Variance of the Proposed Estimator for the AUPEC)
Under Assumptions 2-3, the bias of the estimator given in equation (7) can be bounded as follows,
The variance is given by,
where Z is a Binomial random variable with size n and success probability p f , and for t = 0, 1,
] due to the need to estimate the terms c k/n for all k, and the additional terms account for the variance of estimation. As discussed at the end of Section 2.3, we can consistently estimate the upper bound of bias by assuming that the CATE is Lipschitz continuous. As before, the variance can be consistently estimated by replacing each unknown parameter with its sample analogue, i.e., for t = 0, 1,
In the extreme cases with k → 1 for t = 1 and k → n for t = 0, the denominators in equation (9) are likely to be close to zero. In such cases, we instead use the estimator κ 1 (X i ,ĉ k min /n ) for all k < k min where k min is the smallest k such that equation (9) for κ 1 (X i ,ĉ k/n ) does not suffer from zero in the denominators. Similarly, for t = 0, we use κ 0 (X i ,ĉ kmax/n ) for all k > k max where k max is the largest k such that equation (9) does not suffer from zero in the denominators.
For the terms involving the binomial random variable Z, we first note that these terms when fully expanded out are the polynomials of p f = E(f (X i )). To estimate the polynomials of p f , we can utilize their unbiased estimators as discussed in Stuard and Ord (1994) 
When the sample size is large, this estimation method is not computationally efficient and stable due to the presence of high powers. Hence, we may use the Monte Carlo sampling of Z from a Binomial distribution with size n and success probabilityp f . In our simulation study, we show that this Monte Carlo approach is effective (see Section 3).
Relative Efficacy of Two Individualized Treatment Rules
We may also be interested in evaluating the relative efficacy of two ITRs, f and g. This can be done by estimating the difference in the population average value (PAV) between the two ITRs,
While this quantity is useful in some settings, the problem is the same as the PAV itself; it fails to take into account the number of units assigned to the treatment condition under each ITR.
For example, if a treatment never hurts units, i.e., Y i (1) ≥ Y i (0) for all i, then it is not fair to compare an ITR that treats most of the individuals to another ITR that treats only a few. Such a comparison would not account for how good each ITR is in identifying those who benefit most from the treatment.
To address this issue, we compare the efficacy of two ITRs under a budget contraint. That is, we aim to estimate the difference in the PAPEs under the same budget constraint p. Formally, we define the Population Average Prescriptive Effect Difference (PAPD) under budget p as,
We propose the following estimator of the PAPD,
As before, we derive the bias and variance of this estimator under the Neyman's repeated sampling framework. Although the bias of the proposed estimator in equation (11) is not zero, we derive its upper bound as done in Theorems 2 and 3. Unlike the previous results, however, the variance is not identifiable either in this case. Hence, we derive its upper bound, yielding a conservative variance estimator.
Theorem 4 (Bias and Variance of the Proposed Estimator for the PAPD with a
Budget Constraint) Under Assumptions 2-3, the bias of the proposed estimator of the PAPD with a budget constraint p defined in equation (11) can be bounded as follows,
The variance of the estimator is bounded by,
Proof is given in Appendix A.4. The upper bound of the variance can be estimated by replacing the unknown parameters with their sample analogues in a manner similar to those given in equations (5) and (6). Unlike the case of the PAPE under a budget constraint (see Theorem 2), the variance of the PAPD estimator under a budget constraint is unidentifiable. In the previous case, we have only score s f (X), and the statisticĉ f p helps us anchor its distribution because of the identity, Pr(s f (X) >ĉ f p ) = np /n. In the current case, however, we have two scores,ĉ f p andĉ g p . Unfortunately, we can only identify their marginal distributions from the observed data, and their joint distribution is unidentifiable.
Comparison with the Ex-ante Experimental Evaluation
So far, we have considered an ex-post evaluation, in which we first conduct a randomized experiment and then evaluate ITRs using the data from the experiment. Alternatively, researchers may consider an ex-ante experimental evaluation, in which we conduct a randomized experiment to directly evaluate ITRs. We compare the ex-ante and ex-post evaluations in terms of their statistical efficiency. Intuitively, the ex-post evaluation is likely to be more efficient because the entire sample is used to estimate the PAV for both the ITR of interest and a random assignment rule. In contrast, the ex-ante evaluation uses separate parts of the sample for the estimation of the PAV for the two treatment rules. Although it is difficult to draw a definitive conclusion, the result of our analysis below confirms this intuition.
Suppose we have a simple random sample of n units from the same target population, P.
Consider a completely randomized experiment, in which a total of n f > 2 units are randomly assigned to an ITR f while the remaining units n r = n − n f are assigned to the random treatment rule with the probability of treatment assignment equal to n r1 /n r . Let F i be an indicator variable, which is equal to 1 if unit i is assigned to the ITR f and is equal to 0 otherwise. Under the random treatment rule, the number of units that are randomly assigned to the treatment condition is n r1 while n r0 = n r − n r1 units are assigned to the control condition. As before, we use T i to represent the treatment indicator.
Assumption 4 (Complete Randomization in the Ex-ante Evaluation) For any i = 1, 2, . . . , n, the probability of being assigned to the individualized treatment rule rather than the random treatment rule is given by,
Among those who are assigned to the random treatment rule, i.e., F i = 0, the probability of treatment assignment is given by,
Using this experimental data, we wish to estimate the PAPE defined in equation (1). One potential complication is that we have to adjust for the number of treated units as done throughout this paper since the number of treated units under the random treatment rule may differ from that under the ITR, i.e.,p f = n r1 /n r wherep f = n i=1 f (X i )/n. On the other hand, it is possible to choose the number of treated units under the random treatment rule such that the equality is enforced if the covariate data for the group assigned to the ITR are available before the randomization of treatment assignment. We propose the following estimator of the PAPE for the ex-ante experimental evaluation that accounts for a potential difference in the proportion of treated units between the ITR and the random treatment rule by appropriately weighting the latter,
The ex-ante evaluation differs from the ex-post evaluation in two ways. First, the ex-ante estimator requires two separate randomizations (T i and F i ) while the ex-post estimator only involves one. Intuitively, an additional layer of randomization increases variance. Second, the ex-ante evaluation requires a separate group that follows an ITR, whereas all individuals in the ex-post evaluation are simply randomly assigned either to the treatment or control group. As a result, in the ex-post evaluation, the PAV of the random treatment rule is estimated using the entire sample.
Together, we expect the ex-ante evaluation to be less efficient than the ex-post evaluation. We confirm this intuition under a set of simplifying assumptions below.
Before comparing two modes of evaluation, we derive the bias and variance of the ex-ante estimator under Neyman's repeated sampling framework. In the current case, the uncertainty comes from three types of randomness: (1) the random assignment to the individualized or random treatment rule, (2) the randomized treatment assignment under the random assignment rule, and (3) the simple random sampling of units from the target population. The next theorem shows that this estimator is unbiased and the variance is identifiable.
Theorem 5 (Bias and Variance of the Proposed Ex-Ante Estimator for PAPE) Under Assumptions 2, 1, and 4, the bias and variance of the estimator of the PAPE given in equation (12) are given by,
Proof is given in Appendix A.5. To estimate the variance, we replace the terms with their unbiased estimates.
We now examine the relative statistical efficiency of the ex-post and ex-ante experimental evaluations. This can be done by directly comparing the variances derived in Theorems 1 and 5.
To facilitate the comparison, we assume n 1 = n 0 = n f = n r = n/2. In words, the ex-ante evaluation sets the treatment assignment probability to 1/2, and the ex-post evaluation also sets the probability of being assigned to the ITR to 1/2. Finally, we also assume n r1 = n r0 = n/4, implying that in the ex-post evaluation the treatment assignment probability under the random treatment rule also equals 1/2. Under this setting, the difference in the variance of the PAPE estimator between the ex-ante and ex-post evaluations is given by,
The details of the derivation are given in Appendix A.6.1.
Suppose now that the ITR correctly assigns individuals on average, i.e., E(Y
for t = 0, 1. Under this assumption, the last two terms in the square bracket are positive, i.e.,
E(Y
for t = 0, 1. Hence, the only term that is possibly negative in equation (13) is the third term in the square bracket. This suggests that the ex-post evaluation is more efficient than ex-ante evaluation if this term is sufficiently small.
Unfortunately, it is difficult to generally determine the sign of this variance difference. One reason for this difficulty is that the proposed ex-post evaluation estimatorτ f in equation (2) is not invariant to a constant shift of the outcome variable due to the fact that p f is estimated.
That is, adding a constant δ to Y will change the value ofτ f . Although this does not change the unbiasedness ofτ f , it does alter the variance shown in Theorem 1. Specifically, the variance will have an additional term:
It is natural to choose the value of δ to minimize this extra term of the variance, which yields the following optimal value,
Roughly speaking, the optimal value of δ balances the two potential outcomes around zero after a constant shift, i.e.,
This guarantees that the optimal choice of δ is zero and hence no adjustment in variance is necessary. Under this assumption, we can bound equation (13) from below as follows (see Appendix A.6.2 for details),
This implies that under this simplifying assumption the ex-post evaluation is more efficient than the ex-ante evaluation. Thus, our analysis suggests that the ex-post evaluation may result in a smaller variance than the ex-ante evaluation. At least, there is no clear reason to prefer the ex-ante evaluation over the ex-post evaluation.
A Simulation Study
We conduct a simulation study to examine the finite sample performance of the proposed methodology. We show that the empirical coverage probability of the confidence interval based on the proposed variance converges quickly to its nominal counterpart. We also find that as expected the bias is minimal even when the proposed estimator is not unbiased and the variance bounds are tight.
Data Generation Process
We base our data generating process (DGP) on the one used in the 2017 Atlantic Causal inference Conference (ACIC) Data Analysis Challenge (see Hahn, Dorie and Murray, 2018, for details). The focus of this competition was the estimation and inference for the conditional average treatment effect in observational studies. A total of 8 covariates X are taken from the Infant Health and Development Program (Brooks-Gunn, Liaw and Klebanov, 1992), which originally had 58 covariates and n = 4, 302 observations. In our simulation, we assume that the population distribution of covariates is equal to the empirical distribution based on this data set. Therefore, we obtain each simulation sample via boostrap. We vary the sample size by setting it to either 100, 500, or 2,000.
We use the same outcome model as the one used in the competition,
where π(x) = 1 1 + e 3(x 1 +x 43 +0.3(x 10 −1))−1 µ(x) = − sin(Φ(π(x))) + x 43 τ (x) = ξ(x 3 x 24 + (x 14 − 1) − (x 15 − 1)) with Φ(·) representing the standard Normal CDF and x j indicating a specific covariate in the data set (see Hahn, Dorie and Murray, 2018) . One important difference from the competition is that we assume a complete randomized experiment whereas the original DGP used the treatment assignment mechanism as a function of covariates. As in the original competition, we focus on two scenarios regarding the treatment effect size by setting ξ equal to 2 ("high") and 1/3 ("low").
Although the original DGP included four different types of errors, we focus on the independently, and identically distributed σ(X i ) i where σ(x) = 0.25 V(µ(x) + π(x)τ (x)) and i
∼ N (0, 1).
For illustration, we evaluate the Bayesian Additive Regression Trees (BART) (see Chipman et al., 2010; Hill, 2011; Hahn, Murray and Carvalho, 2017) , which had the best overall performance in the original competition. We also compare this model with two other popular methods: Causal Forest, which is a variant of random forest designed specifically for the estimation of heterogeneous causal effects (Wager and Athey, 2018) as well as the LASSO, which includes all main effect terms and two-way interaction effect terms between the treatment and all covariates (Tibshirani, 1996) . 
To compute the true value of our causal quantities of interest, we use the outcome model specified in equation (15) and evaluate each quantity in the entire original data set. For example, we compute the PAPE as,
f (X i )/n. This computation gives the true value in our simulation setting because we assume the population distribution of covariates is equal to the empirical distribution of the original data set. n = 100 n = 500 n = 2000 
Results
Table 1 presents the estimated bias and standard deviation of each estimator as well as the estimated coverage probability of its 95% confidence intervals based on the normal approximation.
These estimates are based on 1,000 Monte Carlo trials following the procedure described above.
The results are shown separately for two scenarios: high and low treatment effects. Under each scenario, we use three different sample sizes. We first estimate the PAPE for BART τ f without a budget constraint. We also estimate the PAPE with a budget constraint of 20% as the maximal (∆(f, h)). We find that under both scenarios and across sample sizes, the bias of our estimator is small. Moreover, the coverage rate of 95% confidence intervals is close to their nominal rate even when the sample size is quite small. Although we can only bound the variance when estimating the PAPD between two ITRs (i.e., ∆ 0.2 (f, g) and ∆ 0.2 (f, h)), the estimated coverage stay close to 95%.
We next compare the relative efficiency between the ex-ante and ex-post experimental evaluations using the analytical results in Section 2.6. The simulation data we use for the ex-ante evaluation are identical to those used for the ex-post evaluation so that we can make a fair comparison. We assign the half of the sample to the ITR and the other half to the random treatment rule, i.e., n f = n r = n/2. Within the random treatment rule arm, the probability of receiving the treatment is 50%, which is identical to the treatment assignment probability for the ex-post evaluation, i.e., n r1 /n r = n r0 /n r = n 1 /n = n 0 /n = 1/2. Figure 2 presents the result of the comparison for BART by plotting the standard deviation of the PAPE estimator for the ex-ante evaluation (horizontal axis) against that for the ex-post evaluation (vertical axis). We do not present the results for Causal Forest and LASSO as they are sufficiently similar. For both low (red line with solid circles) and high (blue line with solid squares) treatment effect scenarios, the ex-post evaluation estimator is much more efficient than the ex-ante evaluation estimator. This finding is consistent with the analytical result derived under a set of simplifying assumptions in Section 2.6.
An Empirical Application
We apply the proposed methodology to the data from the Tennessee's Student/Teacher Achievement Ratio (STAR) project, which was a four-year longitudinal study experimentally evaluating the impacts of class size in early education on various outcomes (Mosteller, 1995) . We find that Causal Forest generally outperforms BART and LASSO in this application.
Data and Setup
The STAR project randomly assigned over 7,000 students across 79 schools to three different groups: small class (13 to 17 students), regular class (22 to 25 students), and regular class with a full-time teacher's aid. The experiment began when students entered kindergarden and continued through third grade. Since our methodology is applicable only to a binary treatment (an extension to a non-binary treatment is possible but is beyond the scope of this paper), we focus on the first two groups: small class and regular class without an aid. The treatment effect heterogeneity is important here because reducing class size is costly, requiring additional teachers and classrooms.
Policy makers who face a budget constraint may be interested in finding out which groups of students benefit most from small class so that the priority can be given to those students.
We use a total of 10 pre-treatment covariates X i that include four demographic characteristics of students (gender, race, birth month, birth year) and six school characteristics (urban/rural, enrollment size, grade range, number of students on free lunch, number of students on school buses, and percentage of white students). Our treatment variable is the class size to which they were assigned at kindergarten: small class T i = 1 and regular class without an aid T i = 0. For the outcome variables Y i , we use three standardized test scores measured at third grade: SAT math, reading, and writing scores.
The resulting data set has a total of 1,911 observations. We randomly select approximately 70% of the sample (i.e., 1,338 observations) as the training data and the reminder of the sample Table 2 : The Estimated Population Average Prescription Effect (PAPE) for BART, Causal Forest, and LASSO with and without a Budget Constraint. For each of the three outcomes, the point estimate, the standard error, and the proportion treated are shown. The budget constraint considered here implies that the maximum proportion treated is 20%.
(i.e., 573 observations) as the evaluation data. We train the same three machine learning models as the ones used in our simulation study. For Causal Forest, we set tune.parameters = TRUE.
For BART, tuning was done on the number of trees. For LASSO, we tuned the regularization parameter. All tuning were done through the 5-fold cross validation procedure on the training set using the PAPE as the evaluation metric. We then create an ITR as 1{τ (x) > 0} whereτ (x) is the estimated conditional average treatment effect obtained from each fitted model. We will evaluate these ITRs using the evaluation sample.
Results
The upper panel of Table 2 presents the estimated PAPE for the ITRs based on BART, Causal Forest, and LASSO without a budget constraint. We find that without a budget constraint, none of the ITRs based on the machine learning methods significantly improves upon the random treatment rule with two exceptions. The ITR based on Causal Forest performs worse than the random treatment rule for the SAT reading score by more than 19 points (with the standard error of 4.4 points). In addition, the ITR based on LASSO also does worse for the SAT math score by about 16 points (with the standard error of 4.7 points) relative to the random treatment rule.
The results change substantially when we impose a budget constraint. The lower panel of Table 2 presents the results with a budget constraint where the maximum proportion of treated units is 20%. We find that the ITR derived from Causal Forest performs best across all three outcomes. The ITR based on BART performs well though the amount of improvement over the random treatment rule is less than that for the ITR based on Causal Forest. Finally, although the ITR based on LASSO performs better than the random treatment rule for the SAT reading score, this ITR is outperformed by the random treatment rule for the SAT math score. We find that across three test scores both BART and Causal Forest find students who benefit positively from small class when the maximum proportion treated is relatively small. In contrast, LASSO has a difficulty in identifying these individuals. Unfortunately, as the budget constraint is relaxed, the ITRs based on BART and Causal Forest yields the PAPE similar to the one under the random assignment rule. This suggests that they are "over-treating" students, meaning that those who do not necessarily benefit from small class are also treated when little or no budget constraint is imposed.
Concluding Remarks
As the application of individualized treatment rules (ITRs) becomes more widespread in a variety of fields including medicine, business, and politics, a rigorous perfomance evaluation of ITRs becomes essential before policy makers deploy an ITR in a target population. We believe that the inferential approach proposed in this paper provides a robust and widely applicable tool to empirically evaluate the efficacy of ITRs. Furthermore, we provide evidence that ex-post evaluation of ITRs is more efficient than ex-ante evaluation. This opens up opportunities to utilize the existing randomized controlled trial data for the efficient evaluation of ITRs before they are administered in the real world. In addition, although we do not focus on the estimation of ITRs in this paper, the proposed evaluation metrics can be used to tune hyper-parameters when cross validating machine learning algorithms as done in our empirical application. In future research, we plan to consider the extensions of the proposed methodology to other settings, including non-binary treatments, dynamic treatments, and treatment allocations in the presence of interference between units.
A Mathematical Appendix

A.1 Proof of Theorem 1
To prove Theorem 1, we first consider the sample average prescription effect (SAPE),
and its unbiased estimator,
This estimator differs from the estimator of the PAPE by a small factor, i.e.,τ s f = (n − 1)/nτ f . The following lemma derives the bias and variance in the finite sample framework.
Lemma 1 (Bias and Variance of the Estimator for the SAPE) Under Assumptions 2, 1, and 3, the bias and variance of the estimator of the PAPE given in equation (A2) for estimating the SAPE defined in equation (A1) are given by,
Proof For the sake of notational simplicity, let
. Then, we take the expectation with respect to the experimental treatment assignment, i.e., T i ,
To derive the variance, we first rewrite the proposed estimator as,
, and E(D i D j ) = −n 0 n 1 /{n 2 (n− 1)} for i = j, after some algebra, we have,
Now, we prove Theorem 1. Using Lemma 1 and the law of iterated expectation, we have,
We compute the following expectation for t = 0, 1,
Putting them together yields the following bias expression,
We can further rewrite the bias as,
This implies the estimator for the PAPE is unbiased, i.e., E(τ f ) = τ f . To derive the variance, Lemma 1 implies,
Applying Lemma 1 of Nadeau and Bengio (2000) to the first term within the square brackets yields,
where i = j. Focusing on the covariance term, we have,
where the third equality follows from the formula for the covariance of products of two random variables (Bohrnstedt and Goldberger, 1969) . Finally, combining this result with equations (A4) and (A5) yields,
A.2 Proof of Theorem 2
We begin by deriving the variance expression. The derivation proceeds in the same fashion as the one for Theorem 1. The only non-trivial change is the derivation of the covariance term, which we detail below. First, we note that
where the second equality follows from the fact that once conditioned onĉ p = c, exactly np out of n units will be assigned to the treatment condition. Given this result, we can compute the covariance as follows,
Combining this covariance result with the expression for the marginal variances yields the desired variance expression forτ f (ĉ p ). Next, we derive the upper bound of bias. Using the same technique as the proof of Theorem 1, we can rewrite the expectation of the proposed estimator as,
{Y i (f (X i ,ĉ p )) − pY i (1) − (1 − p)Y i (0)} Now, define F (c) = P(s(X i ) ≤ c). Without loss of generality, assumeĉ p > c p (If this is not the case, we simply switch the upper and lower limits of the integrals below). Then, the bias of the estimator is given by,
By the definition ofĉ p , F (ĉ p ) is the np th order statistic of n independent uniform random variables, and thus follows the Beta distribution with the shape and scale parameters equal to np and n − np + 1), respectively. Therefore, we have, P(|F (ĉ p ) − p| > ) = 1 − B(p + , np , n − np + 1) + B(p − , np , n − np + 1)
where B( , α, β) is the incomplete beta function, i.e., B( , α, β) =
Combining with the result above, the desired result follows. 2
Finally, we take the expectation over the sampling of {X i , Y i (1), Y i (0)}:
where the last equality follows from the relation derived in Appendix A.1. For the variance expression, we proceed as follows:
For the first term, we further use the law of total variance by conditioning on the sample, and use the same proof strategy as the one used Appendix A.1 by centering F i via the transformation D i = F i − n f /n. For the second term, we use the results of Neyman (1923) , with the following notation,
for t = 0, 1. Then, the variance becomes, To compute the difference of the variance, we begin by defining the following,
Then, a simple algebraic manipulation yields,
+ ξ where ξ = 1 n 2 τ 2 f − np f (1 − p f )τ 2 + 2(n − 1)(2p f − 1)τ f τ . Given these expressions, the difference is given by,
A 2 i (n 1 − n r0 ) n r0 n 1 (n − 1) + B 2 i (n 0 − n r1 ) n r1 n 0 (n − 1) + D 2 i (n 0 − n f ) n f n 0 (n − 1)
Under the assumption that n 1 = n 0 = n f = n r = n/2 and n r0 = n r1 = n/4, we have, 
